Dissection of long-range heart rate variability: controlled induction of prognostic measures by activity in the laboratory.

D. Roach,Wendy Wilson,D. Ritchie,R. Sheldon

DOI: https://doi.org/10.1016/J.JACC.2004.01.050

IF: 24

2004-06-16

Journal of the American College of Cardiology

Abstract:

What problem does this paper attempt to address?

[Preparation and Characterization of Monoclonal Antibody Against Human Telomeric Repeat Binding Factor 1].

He Huang,Jimin Shi,Qiaofang Chen,Yi Luo,Wei Ding,Jiyu Lou

DOI: https://doi.org/10.3760/j:issn:0253-2727.2002.12.004

2002-01-01

Abstract:OBJECTIVE:To prepare a monoclonal antibody against human telomeric repeat binding factor 1 (TRF1) protein and explore its biological characteristics.METHODS:BALB/c mice were immunized with GST-TRF1(33-277) fusion protein for the preparation of monoclonal antibody by hybridoma technique. The obtained antibody was used for clinical assay by Western-blot and immunohistochemical staining.RESULTS:One strain of hybridoma was obtained. It was confirmed by Western-blot that the antibody specifically recognized the 60 kD TRF1 protein. Immunohistochemical staining of the antibody showed that TRF1 protein located in the cytoplasm of epithelial cells and bone marrow cells.CONCLUSION:A TRF1 monoclonal antibody, with high specificity was developed. It is useful for detection of TRF1 protein in tissue specimens.
Griseofulvin-induced neuropathy

B. Lecky

DOI: https://doi.org/10.1016/0140-6736(90)90328-3

IF: 202.731

1990-01-27

The Lancet

Abstract:
Optical Gaussian pulse generator using phase modulator based spectral slicing and compression

Qiang Wang,L. Huo,Yanfei Xing,C. Lou,Bingkun Zhou

DOI: https://doi.org/10.1364/CLEO_SI.2013.CM4G.4

2013-06-09

Abstract:A 25-GHz 3-ps optical Gaussian pulse generator using phase modulators is experimentally demonstrated with wavelength tunability over C-band. Error-free 100-km transmission of 100-Gb/s OTDM signal is achieved with it.
Enhanced transthyretin tetramer stability following expression of an amyloid disease transsuppressor variant in mammalian cells

Masakazu Kamata,Melisa T. Susanto,Irvin S. Y. Chen

DOI: https://doi.org/10.1002/jgm.1276

2009-02-01

The Journal of Gene Medicine

Abstract:BACKGROUND: The transthyretin (TTR) amyloidosis is an incurable fatal inherited disease that is characterized by progressive peripheral and autonomic neuropathy. It is caused by missense amyloidogenic mutations in the TTR gene that destabilize the native tetrameric state and lead to the cytotoxic misfolded monomeric state. One interesting variant (T119M) stabilizes heterotetramers with amyloidogenic TTR and, in the reported heterozygous individuals, protects the carriers from disease. In the present study, we characterize in vitro and in vivo the ectopic expression of the human T119M mutant, termed a transsuppressor for TTR amyloid disease.METHODS: Lentiviral vectors encoding wild or mutant forms of human TTR were constructed and transduced to the human hepatocellular carcinoma cell line, HepG2, or mice. Heterooligomerization between T119M TTR and amyloidogenic variants was analysed by immunoprecipitation following western blotting.RESULTS: T119M TTR was stably expressed in transduced HepG2 cells and was secreted as an oligomer that can interact with its native partner, retinol-binding protein. Importantly, the T119M TTR formed secreted heterooligomers with amyloidogenic TTR variants, V30M, L55P and V122I, in HepG2 cells that were more stable than the homooligomers of the same amyloidogenic TTR variants. Human T119M TTR also formed heterooligomers with V30M TTR in transduced mice.CONCLUSIONS: The results obtained in the present study demonstrate the stabilization of heterotetramers by T119M TTR in human cells and suggest that gene transfer of T119M TTR may have potential as a gene therapy for TTR amyloidosis.
Mind Over Matter: The Development of The Mental Toughness Scale (MTS)

D. Gill

DOI: https://doi.org/10.1123/tsp.27.1.62

Abstract:Mental Toughness (MT), which refers to an inner focus and commitment to rise above challenges when facing adversity, is viewed as one of the most important psychological attributes in determining success in sport. However, there is little consensus on key components of MT, and existing measures vary greatly while focusing on elite athletes. The purpose of this research was to develop a measure of MT for use with college athletes. Collegiate and noncollegiate athletes (N = 271) completed the original 54-item Mental Toughness Scale (MTS) in study 1. Factor analysis (PCA) results reduced the scale to an 11-item scale, with good reliability and validity as demonstrated by its positive correlations with self-esteem and flow. A second study of college basketball players (N = 143) was conducted to establish the psychometric properties of the MTS. Study 2 demonstrated convergent, divergent and criterion validity through correlations with related measures, and a CFA provided moderate support for the MTS as a one-dimensional measure of mental toughness in sport.
Early diagnosis of transthyretin amyloidosis by detection of monomers in plasma microsamples using a protein crystal-based assay

Diogo Costa-Rodrigues,José P. Leite,Maria João Saraiva,Maria Rosário Almeida,Luís Gales

DOI: https://doi.org/10.1101/2024.02.27.24303425

2024-02-29

Abstract:Amyloid diseases are frequently associated with the appearance of an aberrant form of a protein, whose detection enables early diagnosis. In the case of transthyretin amyloidosis, the aberrant protein – the monomers – constitute the smallest species of the amyloid cascade, which creates engineering opportunities for sensing that remain virtually unexplored. Here, a two-step assay is devised, combining molecular sieving and immunodetection, for quantification of circulating monomeric transthyretin in the plasma. It is shown that mesoporous crystals built from biomolecules can selectively uptake transthyretin monomers up to measurable quantities. Furthermore, it was found that the use of endogenous molecules to produce the host framework drastically reduces unspecific adsorption of plasma proteins at the crystal surface, a feature that was observed with metal-organic frameworks. The assay was used to analyse plasma microsamples of patients and healthy controls. It shows a significant increase in the levels of monomeric transthyretin in the patients, proving its usefulness to establish the monomers as soluble and non-invasive marker of the disease. In addition, the assay can evaluate transthyretin stabilizers, an emergent strategy that broadened the treatment approach to the disease. Sensing the initial event of the transthyretin amyloid cascade with the proposed assay can make the difference for early diagnosis and eliminate the currently adopted invasive biopsies modalities for detection of the final products of the aggregation pathway.

Pathology
Enhanced detection of ATTR amyloid using a nanofibril-based assay

M Mahafuzur Rahman,Benjamin Schmuck,Henrik Hansson,Torleif Härd,Gunilla T Westermark,Mats Sandgren

DOI: https://doi.org/10.1080/13506129.2021.1886072

Amyloid

Abstract:More than 30 proteins and peptides have been found to form amyloid fibrils in human diseases. Fibrils formed by transthyretin (TTR) are associated with ATTR amyloidosis, affecting many vital organs, including the heart and peripheral nervous system. Congo red staining is the gold standard method for detection of amyloid deposits in tissue. However, Congo red staining and amyloid typing methods such as immunofluorescence labelling are limited to relatively large deposits. Detection of small ATTR deposits present at an early stage of the disease could enable timely treatment and prevent severe tissue damage. In this study, we developed an enhanced ATTR amyloid detection method that uses functionalised protein nanofibrils. Using this method, we achieved sensitive detection of monomeric TTR in a microplate immunoassay and immunofluorescence labelling of ex vivo tissue from two patients containing ATTR aggregates. The system's utility was confirmed on sections from a patient with AA amyloidosis and liver sections from inflamed mouse. These results suggest that the detection system constitutes important new technology for highly sensitive detection of microscopic amounts of ATTR amyloid deposited in tissue.
Structure-based probe reveals the presence of large transthyretin aggregates in plasma of ATTR amyloidosis patients

Rose Pedretti,Lanie Wang,Anna Yakubovska,Qiongfang S. Zhang,Binh Nguyen,Justin L. Grodin,Ahmad Masri,Lorena Saelices

DOI: https://doi.org/10.1101/2024.03.09.584228

2024-03-10

Abstract:ATTR amyloidosis is a relentlessly progressive disease caused by the misfolding and systemic accumulation of amyloidogenic transthyretin into amyloid fibrils. These fibrils cause diverse clinical phenotypes, mainly cardiomyopathy and/or polyneuropathy. Little is known about the aggregation of transthyretin during disease development and whether this has implications for diagnosis and treatment. Using the cryogenic electron microscopy structures of mature ATTR fibrils, we developed a peptide probe for fibril detection. With this probe, we have identified previously unknown aggregated transthyretin species in plasma of patients with ATTR amyloidosis. These species are large, non-native, and distinct from monomeric and tetrameric transthyretin. Observations from our study open many questions about the biology of ATTR amyloidosis and reveals a potential diagnostic and therapeutic target.

Molecular Biology
Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor

Rita Costa,Frederico Ferreira-da-Silva,Maria J Saraiva,Isabel Cardoso

DOI: https://doi.org/10.1371/journal.pone.0002899

IF: 3.7

2008-08-06

PLoS ONE

Abstract:Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the deposition of amyloid beta-peptide (A-Beta) in the brain. Transthyretin (TTR) is a tetrameric protein of about 55 kDa mainly produced in the liver and choroid plexus of the brain. The known physiological functions of TTR are the transport of thyroid hormone T(4) and retinol, through binding to the retinol binding protein. TTR has also been established as a cryptic protease able to cleave ApoA-I in vitro. It has been described that TTR is involved in preventing A-Beta fibrilization, both by inhibiting and disrupting A-Beta fibrils, with consequent abrogation of toxicity. We further characterized the nature of the TTR/A-Beta interaction and found that TTR, both recombinant or isolated from human sera, was able to proteolytically process A-Beta, cleaving the peptide after aminoacid residues 1, 2, 3, 10, 13, 14,16, 19 and 27, as determined by mass spectrometry, and reversed phase chromatography followed by N-terminal sequencing. A-Beta peptides (1-14) and (15-42) showed lower amyloidogenic potential than the full length counterpart, as assessed by thioflavin binding assay and ultrastructural analysis by transmission electron microscopy. A-Beta cleavage by TTR was inhibited in the presence of an alphaAPP peptide containing the Kunitz Protease Inhibitor (KPI) domain but not in the presence of the secreted alphaAPP derived from the APP isoform 695 without the KPI domain. TTR was also able to degrade aggregated forms of A-Beta peptide. Our results confirmed TTR as a protective molecule in AD, and prompted A-Beta proteolysis by TTR as a protective mechanism in this disease. TTR may prove to be a useful therapeutic agent for preventing or retarding the cerebral amyloid plaque formation implicated in AD pathology.
Aggregation of Transthyretin by Fluid Agitation

Irina Ritsch,Jane Dyson,Peter E Wright

DOI: https://doi.org/10.1101/2024.11.08.622726

2024-11-11

Abstract:The transthyretin (TTR) tetramer, assembled as a dimer of dimers, transports thyroxine and retinol binding protein in blood plasma and cerebrospinal fluid. Aggregation of wild type or pathogenic variant TTR leads to transthyretin amyloidosis (ATTR), which is associated with neurodegenerative and cardiac disease. The trigger for TTR aggregation under physiological conditions is unknown. The tetramer is extremely stable at neutral pH, but aggregation via tetramer dissociation and monomer misfolding can be induced in vitro by lowering the pH. To elucidate factors that may cause TTR aggregation at neutral pH, we examined the effect of shear forces such as arise from fluid flow in the vascular system. Fluid shear forces were generated by rapidly stirring TTR solutions in conical microcentrifuge tubes. Under agitation, TTR formed β-rich aggregates and fibrils at a rate that was dependent upon protein concentration. The lag time before the onset of agitation-induced aggregation increases as the total TTR concentration is increased, consistent with a mechanism in which the tetramer first dissociates to form monomer that either partially unfolds to enter the aggregation pathway or reassociates to form tetramer. NMR spectra recorded at various time points during the lag phase revealed growth of an aggregation-prone intermediate trapped as a dynamically perturbed tetramer. Enhanced conformational fluctuations in the weak dimer-dimer interface suggests loosening of critical inter-subunit contacts which likely destabilizes the agitated tetramer and predisposes it towards dissociation. These studies provide new insights into the mechanism of aggregation of wild type human TTR under near physiological conditions.

Biophysics
Detection of TTR Amyloid in the Conjunctiva Using a Novel Fluorescent Ocular Tracer

Julie Pilotte,Alex S. Huang,Sami Khoury,Xiaowei Zhang,Ali Tafreshi,Peter Vanderklish,Stella T. Sarraf,Jose S. Pulido,Tatyana Milman

DOI: https://doi.org/10.1167/tvst.13.2.11

2024-02-15

Translational Vision Science & Technology

Abstract:Background: Transthyretin amyloidosis (ATTR) is a significant cause of cardiomyopathy and other morbidities in the elderly and Black Americans. ATTR can be treated with new disease-modifying therapies, but large shortfalls exist in its diagnosis. The objective of this study was to test whether TTR amyloid can be detected and imaged in the conjunctiva using a novel small-molecule fluorescent ocular tracer, with the implication that ATTR might be diagnosable by a simple eye examination.Methods: Three approaches were used in this study. First, AMDX-9101 was incubated with in vitro aggregated TTR protein, and changes in its excitation and emission spectra were quantified. Second, a cadaver eye from a patient with familial amyloid polyneuropathy type II TTR mutation and a vitrectomy sample from an hATTR patient were incubated with AMDX-9101 and counterstained with Congo Red and antibodies to TTR to determine whether AMDX-9101 labels disease-related TTR amyloid deposits in human conjunctiva and eye. Last, imaging of in vitro aggregated TTR amyloid labeled with AMDX-9101 was tested in a porcine ex vivo model, using a widely available clinical ophthalmic imaging device.Results: AMDX-9101 hyper-fluoresced in the presence of TTR amyloid in vitro, labeled TTR amyloid deposits in postmortem human conjunctiva and other ocular tissues and could be detected under the conjunctiva of a porcine eye using commercially available ophthalmic imaging equipment.Conclusions: AMDX-9101 enabled detection of TTR amyloid in the conjunctiva, and the fluorescent binding signal can be visualized using commercially available ophthalmic imaging equipment.Translational Relevance: AMDX-9101 detection of TTR amyloid may provide a potential new and noninvasive test for ATTR that could lead to earlier ATTR diagnosis, as well as facilitate development of new therapeutics.

ophthalmology
Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition

Lorena Saelices,Kevin Chung,Ji H Lee,Whitaker Cohn,Julian P Whitelegge,Merrill D Benson,David S Eisenberg

DOI: https://doi.org/10.1073/pnas.1805131115

2018-07-17

Abstract:Each of the 30 human amyloid diseases is associated with the aggregation of a particular precursor protein into amyloid fibrils. In transthyretin amyloidosis (ATTR), mutant or wild-type forms of the serum carrier protein transthyretin (TTR), synthesized and secreted by the liver, convert to amyloid fibrils deposited in the heart and other organs. The current standard of care for hereditary ATTR is liver transplantation, which replaces the mutant TTR gene with the wild-type gene. However, the procedure is often followed by cardiac deposition of wild-type TTR secreted by the new liver. Here we find that amyloid fibrils extracted from autopsied and explanted hearts of ATTR patients robustly seed wild-type TTR into amyloid fibrils in vitro. Cardiac-derived ATTR seeds can accelerate fibril formation of wild-type and monomeric TTR at acidic pH and under physiological conditions, respectively. We show that this seeding is inhibited by peptides designed to complement structures of TTR fibrils. These inhibitors cap fibril growth, suggesting an approach for halting progression of ATTR.
Correctness criteria of some algorithms for uncertain reasoning using Incidence Calculus

A. Bundy

DOI: https://doi.org/10.1007/BF02432147

1986-06-01

Journal of Automated Reasoning

Abstract:
Characterization of an amyloidogenic intermediate of transthyretin by NMR relaxation dispersion

Benjamin I. Leach,James A. Ferguson,Gareth Morgan,Xun Sun,Gerard Kroon,David Oyen,H. Jane Dyson,Peter E. Wright

DOI: https://doi.org/10.1101/2024.02.16.580707

2024-02-21

Abstract:The aggregation pathway of transthyretin (TTR) proceeds through rate-limiting dissociation of the tetramer and partial misfolding of the monomers, which assemble into amyloid structures through a downhill polymerization mechanism. The structural features of the aggregation-prone monomeric intermediate are poorly understood. Characterization of amyloidogenic intermediates is challenging due to their propensity to aggregate at concentrations necessary for structural studies. NMR relaxation dispersion offers a unique opportunity to characterize these intermediates when they exchange on favorable timescales with NMR-visible ground states. To characterize the structural transitions associated with tetramer dissociation, we have analyzed ground-state chemical shift differences between the native tetramer and an engineered monomer in which the critical F87 side chain is replaced by glutamate. The secondary structure and overall fold of the F87E monomer is similar to that of the tetramer except for β-strand H. This strand populates two conformations, where it is either docked on the protein core or is displaced from the edge of the β-sheet formed by β-strands D, A, G, and H (DAGH β-sheet) and is dynamically disordered. Chemical shift differences derived from analysis of H/ N single, double and zero quantum relaxation dispersion data provide insights into the structure of a low-lying excited state that exchanges with the ground state of the F87E monomer at a rate of 3800 s . Disruption of the subunit interfaces of the TTR tetramer leads to destabilization of edge strands in both β-sheets of the F87E monomer. Conformational fluctuations are propagated through the entire hydrogen bonding network of the DAGH β-sheet, from the inner β-strand H, which forms the strong dimer interface in the TTR tetramer, to outer strand D which is unfolded in TTR fibrils. Fluctuations are also propagated from the AB loop in the weak dimer interface to the EF helix, which undergoes structural remodeling in fibrils. The conformational fluctuations in both regions are enhanced at acidic pH where amyloid formation is most favorable. The relaxation dispersion data provide insights into the conformational dynamics of the amyloidogenic state of monomeric TTR that predispose it for structural remodeling and progression to amyloid fibrils.

Biophysics
Differential Modification of Cys10 Alters Transthyretin's Effect on Beta-Amyloid Aggregation and Toxicity

Lin Liu,Jie Hou,Jiali Du,Robert S. Chumanov,Qingge Xu,Ying Ge,Jeffrey A. Johnson,Regina M. Murphy

DOI: https://doi.org/10.1093/protein/gzp025

2009-01-01

Abstract:Tg2576 mice produce high levels of beta-amyloid (Abeta) and develop amyloid deposits, but lack neurofibrillary tangles and do not suffer the extensive neuronal cell loss characteristic of Alzheimer's disease. Protection from Abeta toxicity has been attributed to up-regulation of transthyretin (TTR), a normal component of plasma and cerebrospinal fluid. We compared the effect of TTR purified from human plasma (pTTR) with that produced recombinantly (rTTR) on Abeta aggregation and toxicity. pTTR slowed Abeta aggregation but failed to protect primary cortical neurons from Abeta toxicity. In contrast, rTTR accelerated aggregation, while effectively protecting neurons. This inverse correlation between Abeta aggregation kinetics and toxicity is consistent with the hypothesis that soluble intermediates rather than insoluble fibrils are the most toxic Abeta species. We carried out a detailed comparison of pTTR with rTTR to ascertain the probable cause of these different effects. No differences in secondary, tertiary or quaternary structure were detected. However, pTTR differed from rTTR in the extent and nature of modification at Cys10. We hypothesize that differential modification at Cys10 regulates TTR's effect on Abeta aggregation and toxicity.
Cationic Surface Charge Engineering of Recombinant Transthyretin Remarkably Increases the Inhibitory Potency Against Amyloid β-Protein Fibrillogenesis

Xiaoding Lin,Ting Xu,Wenqi Hou,Xiaoyan Dong,Yan Sun

DOI: https://doi.org/10.3390/molecules29215023

IF: 4.6

2024-10-25

Molecules

Abstract:The deposition of amyloid β-protein (Aβ) in the brain is the main pathogenesis of Alzheimer's disease (AD). The development of potent inhibitors against Aβ aggregation is one of the effective strategies to combat AD. Endogenous transthyretin (TTR) can inhibit Aβ fibrillization via hydrophobic interactions, but its weak inhibitory potency hinders its application in AD therapy. Here, different recombinant TTRs were designed by cationic surface charge engineering. Compared with TTR, all positively charged recombinant TTRs showed enhanced capability in inhibiting Aβ aggregation, especially the recombinant protein obtained by mutating the acidic amino acid in TTR to arginine (TTR-nR) exhibited excellent inhibitory effect. Among them, TTR-7R remarkably increased the inhibitory potency against Aβ, which could effectively inhibit Aβ40 fibrillization at a very low concentration (0.5 μM). In addition, TTR-7R increased cultured cell viability from 62% to 89%, scavenged amyloid plaques in AD nematodes, and prolonged nematode lifespan by 5 d at 2 μM. Thermodynamic studies demonstrated that TTR-7R, enriching in positive charges, presented hydrophobic interactions and enhanced electrostatic interactions with Aβ40, leading to a significantly enhanced inhibitory capacity of TTR-7R. The research provided insights into the development of efficient recombinant protein inhibitors for AD treatment.

chemistry, multidisciplinary,biochemistry & molecular biology
[TREATMENT OF SQUAMOUS-CELL CARCINOMA METASTASES LOCALIZED IN THE HEAD REGION].

H. Nosek

Abstract:
Transthyretin mutagenesis: impact on amyloidogenesis and disease

Zaida L. Almeida,Daniela C. Vaz,Rui M. M. Brito

DOI: https://doi.org/10.1080/10408363.2024.2350379

IF: 7.721

2024-06-09

Critical Reviews in Clinical Laboratory Sciences

Abstract:Transthyretin (TTR), a homotetrameric protein found in plasma, cerebrospinal fluid, and the eye, plays a pivotal role in the onset of several amyloid diseases with high morbidity and mortality. Protein aggregation and fibril formation by wild-type TTR and its natural more amyloidogenic variants are hallmarks of ATTRwt and ATTRv amyloidosis, respectively. The formation of soluble amyloid aggregates and the accumulation of insoluble amyloid fibrils and deposits in multiple tissues can lead to organ dysfunction and cell death. The most frequent manifestations of ATTR are polyneuropathies and cardiomyopathies. However, clinical manifestations such as carpal tunnel syndrome, leptomeningeal, and ocular amyloidosis, among several others may also occur. This review provides an up-to-date listing of all single amino-acid mutations in TTR known to date. Of approximately 220 single-point mutations, 93% are considered pathogenic. Aspartic acid is the residue mutated with the highest frequency, whereas tryptophan is highly conserved. "Hot spot" mutation regions are mainly assigned to β-strands B, C, and D. This manuscript also reviews the protein aggregation models that have been proposed for TTR amyloid fibril formation and the transient conformational states that convert native TTR into aggregation-prone molecular species. Finally, it compiles the various in vitro TTR aggregation protocols currently in use for research and drug development purposes. In short, this article reviews and discusses TTR mutagenesis and amyloidogenesis, and their implications in disease onset.

medical laboratory technology
Stability and fibril formation properties of human and fish transthyretin, and of the Escherichia coli transthyretin‐related protein

E. Lundberg,G. Westermark,A. Sauer-Eriksson,A. Olofsson

DOI: https://doi.org/10.1111/j.1742-4658.2009.06936.x

2009-04-01

Abstract:Human transthyretin (hTTR) is one of several proteins known to cause amyloid disease. Conformational changes in its native structure result in aggregation of the protein, leading to insoluble amyloid fibrils. The transthyretin (TTR)‐related proteins comprise a protein family of 5‐hydroxyisourate hydrolases with structural similarity to TTR. In this study, we tested the amyloidogenic properties, if any, of sea bream TTR (sbTTR) and Escherichia coli transthyretin‐related protein (ecTRP), which share 52% and 30% sequence identity, respectively, with hTTR. We obtained filamentous structures from all three proteins under various conditions, but, interestingly, different structures displayed different tinctorial properties. hTTR and sbTTR formed thin, curved fibrils at low pH (pH 2–3) that bound thioflavin‐T (thioflavin‐T‐positive) but did not stain with Congo Red (CR) (CR‐negative). Aggregates formed at the slightly higher pH of 4.0–5.5 had different morphology, displaying predominantly amorphous structures. CR‐positive material of hTTR was found in this material, in agreement with previous results. ecTRP remained soluble at pH 2–12 at ambient temperatures. By raising of the temperature, fibril formation could be induced at neutral pH in all three proteins. Most of these temperature‐induced fibrils were thicker and straighter than the in vitro fibrils seen at low pH. In other words, the temperature‐induced fibrils were more similar to fibrils seen in vivo. The melting temperature of ecTRP was 66.7 °C. This is approximately 30 °C lower than the melting temperatures of sbTTR and hTTR. Information from the crystal structures was used to identify possible explanations for the reduced thermostability of ecTRP.

Chemistry,Medicine,Biology
Pathological, biochemical, and biophysical characteristics of the transthyretin variant Y114H (p.Y134H) explain its very mild clinical phenotype

Yoshiki Sekijima,Raúl I Campos,Per Hammarström,K Peter R Nilsson,Tsuneaki Yoshinaga,Kiyoshiro Nagamatsu,Masahide Yazaki,Fuyuki Kametani,Shu-ichi Ikeda

DOI: https://doi.org/10.1111/jns.12143

Abstract:Transthyretin (TTR) is a homotetrameric protein that must misfold in order to form amyloid fibrils. Misfolding includes rate limiting tetramer dissociation, followed by fast tertiary structural changes of the monomer that enable aggregation. Hereditary ATTR amyloidosis is an autosomal dominant genetic disorder with systemic deposition of amyloid fibrils induced by TTR gene mutation. We identified a rare Y114H (p.Y134H) TTR variant in a Japanese patient presenting with late-onset, very mild clinical course. The patient had an extremely low serum variant TTR concentration (18% of total TTR), whereas the composition of variant TTR was 55% in amyloid fibrils in tenosynovial tissues obtained at carpal tunnel release surgery. The amyloid fibril deposits in the ATTR Y114H patient had an altered structure compared with that in wild-type ATTR patients, as determined by luminescent conjugated poly/oligo-thiophene fluorescence spectroscopy. Biophysical studies using recombinant protein showed that Y114H TTR was markedly destabilized both thermodynamically and kinetically and was highly amyloidogenic in vitro. These data suggest that extremely low serum variant Y114H TTR concentration, probably due to endoplasmic reticulum-associated degradation of unstable variant TTR protein, protected this patient from severe amyloidosis, as self-assembly of the amyloidogenic intermediate is a concentration-dependent process.

Dissection of long-range heart rate variability: controlled induction of prognostic measures by activity in the laboratory.

[Preparation and Characterization of Monoclonal Antibody Against Human Telomeric Repeat Binding Factor 1].

Griseofulvin-induced neuropathy

Optical Gaussian pulse generator using phase modulator based spectral slicing and compression

Enhanced transthyretin tetramer stability following expression of an amyloid disease transsuppressor variant in mammalian cells

Mind Over Matter: The Development of The Mental Toughness Scale (MTS)

Early diagnosis of transthyretin amyloidosis by detection of monomers in plasma microsamples using a protein crystal-based assay

Enhanced detection of ATTR amyloid using a nanofibril-based assay

Structure-based probe reveals the presence of large transthyretin aggregates in plasma of ATTR amyloidosis patients

Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor

Aggregation of Transthyretin by Fluid Agitation

Detection of TTR Amyloid in the Conjunctiva Using a Novel Fluorescent Ocular Tracer

Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition

Correctness criteria of some algorithms for uncertain reasoning using Incidence Calculus

Characterization of an amyloidogenic intermediate of transthyretin by NMR relaxation dispersion

Differential Modification of Cys10 Alters Transthyretin's Effect on Beta-Amyloid Aggregation and Toxicity

Cationic Surface Charge Engineering of Recombinant Transthyretin Remarkably Increases the Inhibitory Potency Against Amyloid β-Protein Fibrillogenesis

[TREATMENT OF SQUAMOUS-CELL CARCINOMA METASTASES LOCALIZED IN THE HEAD REGION].

Transthyretin mutagenesis: impact on amyloidogenesis and disease

Stability and fibril formation properties of human and fish transthyretin, and of the Escherichia coli transthyretin‐related protein

Pathological, biochemical, and biophysical characteristics of the transthyretin variant Y114H (p.Y134H) explain its very mild clinical phenotype